Immunhämolytische

Immunhämolytische is a German term referring to immune-mediated hemolytic anemia. This condition occurs when the body's immune system mistakenly attacks and destroys its own red blood cells. Red blood cells are crucial for transporting oxygen throughout the body, and their destruction leads to a deficiency in oxygen-carrying capacity, known as anemia.

The immune system typically defends the body against foreign invaders like bacteria and viruses. However, in immune-mediated hemolytic anemia, autoantibodies are produced that target specific antigens on the surface of red blood cells. These autoantibodies can bind to red blood cells, marking them for destruction by other components of the immune system, such as macrophages or the complement system.

There are several subtypes of immunhämolytische, often classified by the temperature at which the autoantibodies are most active. These include warm autoimmune hemolytic anemia, where antibodies are effective at body temperature, and cold agglutinin disease, where antibodies function best at cooler temperatures. Other causes can involve drug-induced antibodies or specific underlying diseases like certain lymphomas or autoimmune disorders.

Symptoms of immunhämolytische can vary depending on the severity of the anemia and the rate of red blood cell destruction. Common signs include fatigue, paleness, shortness of breath, jaundice (yellowing of the skin and eyes due to increased bilirubin from red blood cell breakdown), and an enlarged spleen. Diagnosis typically involves blood tests, including a complete blood count, direct antiglobulin test (Coombs test), and antibody screening. Treatment strategies aim to suppress the immune system's attack on red blood cells and may include corticosteroids, immunosuppressive drugs, or, in some cases, blood transfusions.